Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Teleflex Incorporated and its executives following the abrupt departure of CEO Liam Kelly, which led to a significant drop in the company's stock price [1][3]. Group 1: Company Developments - On January 8, 2026, Teleflex announced the immediate departure of Liam Kelly as Chairman, President, and CEO [3]. - Following this announcement, Teleflex's stock price decreased by $16.52 per share, representing a 13.06% decline, closing at $110.01 per share [3]. Group 2: Legal Investigation - Pomerantz LLP is representing investors in investigating claims against Teleflex regarding possible securities fraud or other unlawful business practices [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the class action [2].

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Blue Owl and certain of its ...

Core Viewpoint - A class action lawsuit has been filed against Jayud Global Logistics Ltd. for alleged securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The lawsuit claims that Jayud and certain officers/directors engaged in securities fraud [2]. - Investors have until January 19, 2026, to request to be appointed as Lead Plaintiff if they purchased Jayud securities during the Class Period [2]. - A copy of the Complaint is available at Pomerantz LLP's website [2]. Group 2: Allegations Against Jayud - The complaint alleges that Jayud failed to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [4]. - It is claimed that insiders or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [4]. - Jayud's public statements and risk disclosures allegedly omitted mention of false rumors and artificial trading activity that influenced the stock price [4]. - As a result of these actions, the positive statements made by the defendants regarding the company's business and prospects were materially misleading [4].

The lead plaintiff deadline is March 13, 2026. RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities fraud class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works†) (NYSE: BBWI) on behalf of those who purchased or otherwise acquired Bath & Body Works securities between June 4, 2024, and November 19, 2025, inclusive (the "Class Period†). The complaint alleges that, throughout the Class Period, De ...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 20, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) ("Integer" or the "Company") on behalf of investors who purchased or otherwise acquired Integer securities during the period of July 25, 2024 through October 22, 2025 (the "Class Period"), inclusive.Investor Deadline: Investors who purchased Integer securities during the Class Period may, no ...

Core Points - A securities class action lawsuit has been filed against CoreWeave, Inc. and certain executives, representing investors who acquired CoreWeave securities between March 28, 2025, and December 15, 2025 [1] - The lawsuit is a response to delays from a third-party data center developer, which has negatively impacted CoreWeave's share price [2] - Hagens Berman, a national shareholder rights firm, is investigating claims that CoreWeave misled investors, urging those who suffered losses to come forward [3] Financial Impact - The lawsuit alleges that CoreWeave made misleading statements regarding its ability to meet customer demand and revenue recognition from long-term contracts [4][5] - Following the Q3 2025 financial results announcement on November 10, 2025, CoreWeave reduced its full-year revenue guidance, attributing it to delays from a third-party data center developer [6] - The share price of CoreWeave fell by $36.11, a decrease of 34%, resulting in a loss of approximately $14 billion in market capitalization within a month [6] Allegations of Misleading Information - The complaint claims that CoreWeave overstated its capabilities and failed to disclose the risks associated with reliance on a single third-party data center supplier [5] - Reports indicated that the third-party supplier, Core Scientific, had been flagging delays since February 2025, which CoreWeave did not adequately communicate to investors [6]

Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. on behalf of investors who acquired StubHub securities during the specified Class Period, highlighting potential undisclosed issues related to the company's IPO [1][3]. Group 1: Lawsuit Details - The lawsuit is initiated by Berger Montague PC, representing investors who purchased StubHub securities from September 14, 2025, to November 24, 2025, including shares from the September 2025 IPO [1][2]. - Investors have until January 23, 2026, to seek appointment as lead plaintiff representatives of the class [2]. Group 2: Allegations Against StubHub - The complaint alleges that StubHub's IPO Registration Statement failed to disclose significant changes in the timing of payments to vendors, which adversely affected the company's free cash flow [3].

SAN DIEGO, Jan. 20, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Wealthfront Corporation (NASDAQ: WLTH). If you have information that could assist in the Wealthfront investigation or if you are a Wealthfront investor who suffered a loss and would like to learn more, you can provide your information here: https://www.rgrdlaw.com/cases-wealthfront-corporation-investigation-wlth.html Past results do not gua ...

Core Viewpoint - Kaskela Law LLC is investigating Select Medical Holdings Corporation to determine potential violations of securities laws or breaches of fiduciary duties by the company and its officers and directors in relation to recent corporate actions [1]. Group 1 - The investigation is initiated on behalf of Select Medical shareholders [1]. - Shareholders are encouraged to contact Kaskela Law LLC for more information regarding their legal rights and options [2]. - Kaskela Law LLC specializes in representing investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis [2].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry items [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was effective in driving topline growth [5]. Group 3: Stock Performance and Financial Results - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 results on November 20, 2025, which included a further reduction in full-year guidance and acknowledgment that the strategy had not grown the customer base, the stock fell by $5.22 per share, or 24.8% [7].